David Ray

David Ray is an accomplished professional with a diverse educational background and extensive experience in healthcare and pharmaceuticals.

He holds a Master of Public Health (M.P.H.) with a focus on Quantitative Methods - Biostatistics from Rutgers, The School of Public Health, a Master of Business Administration (M.B.A.) in Management from Seton Hall University, and a Doctor of Pharmacy (Pharm.D.) from Saint John's University.

David currently serves as the Executive Director of Global HEOR at Karyopharm Therapeutics Inc. Prior to this role, he held leadership positions at renowned organizations such as Epizyme and Ipsen Biopharmaceuticals, where he led various teams focusing on Health Economics and Outcomes Research (HEOR).

With a rich background that includes roles like Senior Director, Head of Global HEOR, Director, and Associate Director at Ipsen Biopharmaceuticals, David has established himself as an expert in the field of HEOR.

His experience also extends to Novartis Oncology, where he contributed as a Health Outcomes, Value and Access Fellow, showcasing his versatility and commitment to the pharmaceutical industry.

Prior to his strategic roles in HEOR, David gained practical experience as a Staff Pharmacist at Hackensack University Medical Center, bringing a unique perspective to his current leadership positions.

David Ray's educational achievements, combined with his progressive career trajectory and leadership roles, underscore his proficiency in healthcare management, biostatistics, pharmacology, and health economics.

He continues to make significant contributions to the field of pharmaceuticals through his current role at Karyopharm Therapeutics Inc., where he leads the Global HEOR department with a wealth of experience and expertise.